K182757 is an FDA 510(k) clearance for the Espire Elbow Pro, Espire Elbow Hybrid. Classified as Electrode, Cutaneous (product code GXY), Class II - Special Controls.
Submitted by College Park Industries, Inc. (Warren, US). The FDA issued a Cleared decision on November 29, 2018 after a review of 62 days - a notably fast clearance cycle.
This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1320 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.